Differential regulation of survivin expression and apoptosis by vitamin D 3 compounds in two isogenic MCF-7 breast cancer cell sublines

Fengzhi Li, Xiang Ling, Huayi Huang, Lisa Brattain, Pasha Apontes, Jianguo Wu, Lise Binderup, Michael G Brattain

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Although both the antiapoptotic function of survivin and vitamin D 3 (VD3)-mediated cell growth inhibition and apoptosis have been extensively studied, it is not known whether survivin plays a role in VD3 compound-mediated cell growth inhibition and apoptosis induction. Using an isogenic model of MCF-7 breast adenocarcinoma cells (MCF-7E and MCF-7L sublines that are sensitive and resistant to VD3 compounds), we found that VD3 compounds effectively downregulated survivin in VD3-sensitive MCF-7E cells, which was associated with VD3-induced apoptosis. In contrast, VD3 compounds failed to downregulate survivin in VD3-resistant MCF-7L cells, which showed resistant to VD3-induced apoptosis. However, inhibition of survivin expression by small interfering RNA (siRNA) induced cell death per se and further sensitized VD3-induced apoptosis in MCF-7L cells, indicating that the inability of these cells to respond to VD3 is due to the failure to downregulate survivin. Forced expression of survivin not only blocked VD3-mediated G1 cell accumulation but also increased S and G2/M cell populations. VD3 treatment rapidly triggered the activation of p38 MAPK signaling in MCF-7E cells but not in MCF-7L cells. Moreover, inhibition of p38 activation diminished VD3-mediated survivin inhibition and partially rescued VD3-induced cell death. We further showed that VD3 increased the expression of TGFβ1 and TGFβ receptor 2, and that blocking the function of TGFβ receptor 2 diminished VD3 compound-mediated survivin downregulation. Thus, we propose that the VD3 compound-induced growth inhibition and apoptosis induction are at least partially dependent on survivin downregulation via VD3-induced TGFβ signaling and the activation of p38 MAPK pathway. Targeting survivin through these pathways may lead to novel applications for cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)1385-1395
Number of pages11
JournalOncogene
Volume24
Issue number8
DOIs
StatePublished - Feb 17 2005

Fingerprint

Cholecalciferol
Apoptosis
Breast Neoplasms
Down-Regulation
p38 Mitogen-Activated Protein Kinases
Cell Death
Growth

Keywords

  • Apoptosis
  • MCF-7 breast cancer cell
  • Survivin
  • Vitamin D
  • p38 MAPK

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Differential regulation of survivin expression and apoptosis by vitamin D 3 compounds in two isogenic MCF-7 breast cancer cell sublines . / Li, Fengzhi; Ling, Xiang; Huang, Huayi; Brattain, Lisa; Apontes, Pasha; Wu, Jianguo; Binderup, Lise; Brattain, Michael G.

In: Oncogene, Vol. 24, No. 8, 17.02.2005, p. 1385-1395.

Research output: Contribution to journalArticle

Li, F, Ling, X, Huang, H, Brattain, L, Apontes, P, Wu, J, Binderup, L & Brattain, MG 2005, ' Differential regulation of survivin expression and apoptosis by vitamin D 3 compounds in two isogenic MCF-7 breast cancer cell sublines ', Oncogene, vol. 24, no. 8, pp. 1385-1395. https://doi.org/10.1038/sj.onc.1208330
Li, Fengzhi ; Ling, Xiang ; Huang, Huayi ; Brattain, Lisa ; Apontes, Pasha ; Wu, Jianguo ; Binderup, Lise ; Brattain, Michael G. / Differential regulation of survivin expression and apoptosis by vitamin D 3 compounds in two isogenic MCF-7 breast cancer cell sublines In: Oncogene. 2005 ; Vol. 24, No. 8. pp. 1385-1395.
@article{f6df8e3a8b5148938f85a6f408a85306,
title = "Differential regulation of survivin expression and apoptosis by vitamin D 3 compounds in two isogenic MCF-7 breast cancer cell sublines",
abstract = "Although both the antiapoptotic function of survivin and vitamin D 3 (VD3)-mediated cell growth inhibition and apoptosis have been extensively studied, it is not known whether survivin plays a role in VD3 compound-mediated cell growth inhibition and apoptosis induction. Using an isogenic model of MCF-7 breast adenocarcinoma cells (MCF-7E and MCF-7L sublines that are sensitive and resistant to VD3 compounds), we found that VD3 compounds effectively downregulated survivin in VD3-sensitive MCF-7E cells, which was associated with VD3-induced apoptosis. In contrast, VD3 compounds failed to downregulate survivin in VD3-resistant MCF-7L cells, which showed resistant to VD3-induced apoptosis. However, inhibition of survivin expression by small interfering RNA (siRNA) induced cell death per se and further sensitized VD3-induced apoptosis in MCF-7L cells, indicating that the inability of these cells to respond to VD3 is due to the failure to downregulate survivin. Forced expression of survivin not only blocked VD3-mediated G1 cell accumulation but also increased S and G2/M cell populations. VD3 treatment rapidly triggered the activation of p38 MAPK signaling in MCF-7E cells but not in MCF-7L cells. Moreover, inhibition of p38 activation diminished VD3-mediated survivin inhibition and partially rescued VD3-induced cell death. We further showed that VD3 increased the expression of TGFβ1 and TGFβ receptor 2, and that blocking the function of TGFβ receptor 2 diminished VD3 compound-mediated survivin downregulation. Thus, we propose that the VD3 compound-induced growth inhibition and apoptosis induction are at least partially dependent on survivin downregulation via VD3-induced TGFβ signaling and the activation of p38 MAPK pathway. Targeting survivin through these pathways may lead to novel applications for cancer therapeutics.",
keywords = "Apoptosis, MCF-7 breast cancer cell, Survivin, Vitamin D, p38 MAPK",
author = "Fengzhi Li and Xiang Ling and Huayi Huang and Lisa Brattain and Pasha Apontes and Jianguo Wu and Lise Binderup and Brattain, {Michael G}",
year = "2005",
month = "2",
day = "17",
doi = "10.1038/sj.onc.1208330",
language = "English (US)",
volume = "24",
pages = "1385--1395",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Differential regulation of survivin expression and apoptosis by vitamin D 3 compounds in two isogenic MCF-7 breast cancer cell sublines

AU - Li, Fengzhi

AU - Ling, Xiang

AU - Huang, Huayi

AU - Brattain, Lisa

AU - Apontes, Pasha

AU - Wu, Jianguo

AU - Binderup, Lise

AU - Brattain, Michael G

PY - 2005/2/17

Y1 - 2005/2/17

N2 - Although both the antiapoptotic function of survivin and vitamin D 3 (VD3)-mediated cell growth inhibition and apoptosis have been extensively studied, it is not known whether survivin plays a role in VD3 compound-mediated cell growth inhibition and apoptosis induction. Using an isogenic model of MCF-7 breast adenocarcinoma cells (MCF-7E and MCF-7L sublines that are sensitive and resistant to VD3 compounds), we found that VD3 compounds effectively downregulated survivin in VD3-sensitive MCF-7E cells, which was associated with VD3-induced apoptosis. In contrast, VD3 compounds failed to downregulate survivin in VD3-resistant MCF-7L cells, which showed resistant to VD3-induced apoptosis. However, inhibition of survivin expression by small interfering RNA (siRNA) induced cell death per se and further sensitized VD3-induced apoptosis in MCF-7L cells, indicating that the inability of these cells to respond to VD3 is due to the failure to downregulate survivin. Forced expression of survivin not only blocked VD3-mediated G1 cell accumulation but also increased S and G2/M cell populations. VD3 treatment rapidly triggered the activation of p38 MAPK signaling in MCF-7E cells but not in MCF-7L cells. Moreover, inhibition of p38 activation diminished VD3-mediated survivin inhibition and partially rescued VD3-induced cell death. We further showed that VD3 increased the expression of TGFβ1 and TGFβ receptor 2, and that blocking the function of TGFβ receptor 2 diminished VD3 compound-mediated survivin downregulation. Thus, we propose that the VD3 compound-induced growth inhibition and apoptosis induction are at least partially dependent on survivin downregulation via VD3-induced TGFβ signaling and the activation of p38 MAPK pathway. Targeting survivin through these pathways may lead to novel applications for cancer therapeutics.

AB - Although both the antiapoptotic function of survivin and vitamin D 3 (VD3)-mediated cell growth inhibition and apoptosis have been extensively studied, it is not known whether survivin plays a role in VD3 compound-mediated cell growth inhibition and apoptosis induction. Using an isogenic model of MCF-7 breast adenocarcinoma cells (MCF-7E and MCF-7L sublines that are sensitive and resistant to VD3 compounds), we found that VD3 compounds effectively downregulated survivin in VD3-sensitive MCF-7E cells, which was associated with VD3-induced apoptosis. In contrast, VD3 compounds failed to downregulate survivin in VD3-resistant MCF-7L cells, which showed resistant to VD3-induced apoptosis. However, inhibition of survivin expression by small interfering RNA (siRNA) induced cell death per se and further sensitized VD3-induced apoptosis in MCF-7L cells, indicating that the inability of these cells to respond to VD3 is due to the failure to downregulate survivin. Forced expression of survivin not only blocked VD3-mediated G1 cell accumulation but also increased S and G2/M cell populations. VD3 treatment rapidly triggered the activation of p38 MAPK signaling in MCF-7E cells but not in MCF-7L cells. Moreover, inhibition of p38 activation diminished VD3-mediated survivin inhibition and partially rescued VD3-induced cell death. We further showed that VD3 increased the expression of TGFβ1 and TGFβ receptor 2, and that blocking the function of TGFβ receptor 2 diminished VD3 compound-mediated survivin downregulation. Thus, we propose that the VD3 compound-induced growth inhibition and apoptosis induction are at least partially dependent on survivin downregulation via VD3-induced TGFβ signaling and the activation of p38 MAPK pathway. Targeting survivin through these pathways may lead to novel applications for cancer therapeutics.

KW - Apoptosis

KW - MCF-7 breast cancer cell

KW - Survivin

KW - Vitamin D

KW - p38 MAPK

UR - http://www.scopus.com/inward/record.url?scp=14844295739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844295739&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208330

DO - 10.1038/sj.onc.1208330

M3 - Article

VL - 24

SP - 1385

EP - 1395

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 8

ER -